Sotalol oral solution - Arbor Pharmaceuticals

Drug Profile

Sotalol oral solution - Arbor Pharmaceuticals

Alternative Names: AR05; Sotalol hydrochloride oral solution - Arbor Pharmaceuticals; Sotylize

Latest Information Update: 02 Jan 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Arbor Pharmaceuticals
  • Class Antihypertensives; Class III antiarrhythmics; Ethanolamines
  • Mechanism of Action Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Atrial fibrillation; Atrial flutter; Ventricular arrhythmias

Most Recent Events

  • 23 Oct 2014 Registered for Atrial fibrillation in USA (PO)
  • 23 Oct 2014 Registered for Atrial flutter in USA (PO)
  • 23 Oct 2014 Registered for Ventricular arrhythmias in USA (PO) - First global approval
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top